|
1）Adamovic T, Riou EM, Bernard G, et al. Acute combined central and peripheral nervous system demyelination in children. Pediatr Neurol. 2008; 39: 307-16
|
|
|
|
2）Kawamura N, Yamasaki R, Yonekawa T, et al. Anti-neurofascin antibody in patients with combined central and peripheral demyelination. Neurology. 2013; 81: 714-22
|
|
|
|
|
|
3）Salzer JL, Brophy PJ, Peles E. Molecular domains of myelinated axons in the peripheral nervous system. Glia. 2008; 56: 1532-40
|
|
|
|
|
|
4）Buttermore ED, Thaxton CL, Bhat Ma. Organization and maintenance of molecular domains in myelinated axons. J Neurosci Res. 2013; 91: 603-22
|
|
|
|
|
|
5）Black Ja, Waxman SG. The perinodal astrocyte. Glia. 1988; 1: 169-83
|
|
|
|
|
|
6）Feinberg K, Eshed-Eisenbach Y, Frechter S, et al. A glial signal consisting of gliomedin and NrCAM clusters axonal Na＋ channels during the formation of nodes of Ranvier. Neuron. 2010; 65: 490-502
|
|
|
|
|
|
7）Susuki K, Chang K, Zollinger DR, et al. Three mechanisms assemble central nervous system nodes of Ranvier. Neuron. 2013; 78: 469-82
|
|
|
|
|
|
8）Sherman DL, Tait S, Melrose S, et al. Neurofascins are required to establish axonal domains for saltatory conduction. Neuron. 2005; 48: 737-42
|
|
|
|
|
|
9）Traka M, Goutebroze L, Denisenko N, et al. Association of TAG-1 with Caspr2 is essential for the molecular organization of juxtaparanodal regions of myelinated fibers. J Cell Biol. 2003; 162: 1161-72
|
|
|
|
|
|
10）Rathjen FG, Wolff JM, Chang S, et al. Neurofascin: a novel chick cell-surface glycoprotein involved in neurite-neurite interactions. Cell. 1987; 51: 841-9
|
|
|
|
|
|
11）Volkmer H, Hassel B, Wolff JM, et al. Structure of the axonal surface recognition molecule neurofascin and its relationship to a neural subgroup of the immunoglobulin superfamily. J Cell Biol. 1992; 118: 149-61
|
|
|
|
|
|
12）Barclay AN. Membrane proteins with immunoglobulin-like domains - a master superfamily of interaction molecules. Semin Immunol. 2003; 15: 215-23
|
|
|
|
|
|
13）Thaxton C, Pillai AM, Pribisko AL, et al. In vivo deletion of immunoglobulin domains 5 and 6 in neurofascin (Nfasc) reveals domain-specific requirements in myelinated axons. J Neurosci. 2010; 30: 4868-76
|
|
|
|
|
|
14）Zonta B, Tait S, Melrose S, et al. Glial and neuronal isoforms of Neurofascin have distinct roles in the assembly of nodes of Ranvier in the central nervous system. J Cell Biol. 2008; 181: 1169-77
|
|
|
|
|
|
15）Misawa S, Kuwabara S, Mori M, et al. Peripheral nerve demyelination in multiple sclerosis. Clin Neurophysiol. 2008; 119: 1829-33
|
|
|
|
|
|
16）Zee PC, Cohen BA, Walczak T, et al. Peripheral nervous system involvement in multiple sclerosis. Neurology. 1991; 41: 457-60
|
|
|
|
|
|
17）Gartzen K, Katzarava Z, Diener H, et al. Peripheral nervous system involvement in multiple sclerosis. Eur J Neurol. 2011; 18: 789-91
|
|
|
|
|
|
18）Bouchard C, Lacroix C, Plante V, et al. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology. 1999; 52: 498-503
|
|
|
|
|
|
19）Zéphir H, Stojkovic T, Latour P, et al. Relapsing demyelinating disease affecting both the central and peripheral nervous systems. J Neurol Neurosurg Psychiatr. 2008; 79: 1032-9
|
|
|
|
|
|
20）Mathey EK, Derfuss T, Storch MK, et al. Neurofascin as a novel target for autoantibody-mediated axonal injury. J Exp Med. 2007; 204: 2363-72
|
|
|
|
|
|
21）Lindner M, Ng JKM, Hochmeister S, et al. Neurofascin 186 specific autoantibodies induce axonal injury and exacerbate disease severity in experimental autoimmune encephalomyelitis. Exp Neurol. 2013; 247: 259-66
|
|
|
|
|
|
22）Pomicter AD, Shroff SM, Fuss B, et al. Novel forms of neurofascin 155 in the central nervous system: alterations in paranodal disruption models and multiple sclerosis. Brain. 2010; 133: 389-405
|
|
|
|
|
|
23）Ng JKM, Malotka J, Kawakami N, et al. Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology. 2012; 79: 2241-8
|
|
|
|
|
|
24）Querol L, Nogales-Gadea G, Rojas-Garcia R, et al. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology. 2014; 82: 879-86
|
|
|
|
|
|
25）Prüss H, Schwab JM, Derst C, et al. Neurofascin as target of autoantibodies in Guillain-Barre syndrome. Brain. 2011; 134: e173; author reply e174
|
|
|
|
|
|
26）Devaux JJ, Odaka M, Yuki N. Nodal proteins are target antigens in Guillain-Barré syndrome. J Peripher Nerv Syst. 2012; 17: 62-71
|
|
|
|
|
|
27）Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012; 366: 539-51
|
|
|
|
|